The Office of New Drugs at the FDA is in the middle of a major, phased reorganization at the moment. All divisions are impacted, including Neurology, which will be split in two, and Psychiatry.
As part of the reorganization, starting this month, a new Office of Rare Diseases, Paediatrics, Urological & Reproductive Medicine will be formed. In addition, there will be new divisions created for Pharm/Tox for Neuroscience and Pharm/Tox for Rare Diseases, Paediatrics, Urological & Reproductive Medicine.
https://www.fda.gov/drugs/regulator...nges-office-translational-sciences-and-office
How long?., page-13
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.71 |
Change
-0.590(3.41%) |
Mkt cap ! $2.135B | |||
| Open | High | Low | Value | Volume |
| $17.50 | $17.55 | $16.57 | $10.01M | 594.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 598 | $16.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.87 | 1676 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |